This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies
at the country level. The country profile se...ries are designed as a quick reference source for development practitioners to better
integrate climate resilience in development planning and policy making.
more
Profile of Crisis Response of District Health or Disaster Risk at East Halmahera District, Indonesia
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...health authorities at both the national and facility level.
more
Profile of Crisis Response of District Health / Disaster Risk: Regency of Pulang Pisau, Indonesia
El propósito de este documento es presentar orientaciones para mejorar la aplicación de medidas de salud pública no farmacológicas durante la respuesta a la COVID-19, así como la adherencia a dichas medidas por parte de los grupos de población en situación de vulnerabilidad. Para ello, es nec...esario identificar los principales obstáculos a la aplicación de las medidas, lo que nos permite determinar los grupos y territorios más afectados en las diferentes fases de la pandemia. Con este objetivo, y desde un marco de equidad, derechos humanos y diversidad, se recomiendan políticas, estrategias e intervenciones que acompañan la aplicación y flexibilización de las medidas, de modo que nadie quede atrás.
more
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...als testing the efficacy and safety of several medicines for COVID-19, as of the date of this document, there is a lack of quality evidence to demonstrate chloroquine and/or hydroxychloroquine are effective in the treatment of COVID-19. Evidence is recently emerging via small studies with sub-optimal methodologies that are conflicting.
more
Scientific Brief, 30 June 2020
PLoS Medicine Vol. 6 no. 10 (2009) e1000165
РУКОВОДСТВО ДЛЯ АКТИВИСТОВ ПО ИНСТРУМЕНТАМ ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА ЯНВАРЬ.
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...; violence; lack of community empowerment and other violations of human rights. These sociostructural factors limit access to health services, constrain how these services are
delivered and diminish their effectiveness.
more
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.